Goins Melanie F 4
4 · 1stdibs.com, Inc. · Filed Mar 17, 2026
Research Summary
AI-generated summary of this filing
1stdibs (DIBS) GC Melanie Goins Receives 138,300 RSUs
What Happened
Melanie F. Goins, General Counsel and Chief Product Officer of 1stdibs.com, was granted 138,300 restricted stock units (RSUs) (derivative award) on March 13, 2026 and also executed small open-market sales totaling 100 shares across March 13–17, 2026. The RSUs were reported at $0 (they are a contingent right to receive stock). The sales comprised 7 shares on 3/13, 69 shares on 3/16, and 24 shares on 3/17 for aggregate proceeds of $551 (weighted-average prices around $5.50–$5.52).
Key Details
- Transaction dates and prices:
- 2026-03-13: Sold 7 shares at $5.50 — $39 (reported as weighted-average)
- 2026-03-16: Sold 69 shares at $5.50 — $380 (reported as weighted-average)
- 2026-03-17: Sold 24 shares at $5.52 — $132 (reported as weighted-average)
- 2026-03-13: Awarded 138,300 RSUs at $0 (derivative award)
- Total sold: 100 shares for ~$551 in proceeds.
- RSU details (footnotes): Each RSU equals the right to one share. The initial grant vests in 12 equal quarterly installments beginning June 8, 2026, subject to continued service; the RSUs have no expiration.
- Trading plan/price notes: The sales were effected pursuant to a Rule 10b5-1 trading plan adopted December 9, 2025. The filing reports weighted-average prices and notes the sales occurred in multiple trades at prices in the $5.50–$5.54 range.
- Shares owned after transaction: Not specified in the filing.
Context
- The RSU grant is a compensation award (not an immediate purchase) and vests over time; it represents future economic exposure if/when vested shares are delivered.
- The small open-market sales were executed under a pre-established 10b5-1 plan; such planned sales are commonly used for routine diversification or liquidity and do not, by themselves, indicate management sentiment.
Insider Transaction Report
Form 4
Goins Melanie F
General Counsel and CPO
Transactions
- Sale
Common Stock
[F1]2026-03-13$5.50/sh−7$39→ 221,611 total - Sale
Common Stock
[F1][F2]2026-03-16$5.50/sh−69$380→ 221,542 total - Sale
Common Stock
[F1][F3]2026-03-17$5.52/sh−24$132→ 221,518 total - Award
Restricted Stock Units
[F4][F5]2026-03-13+138,300→ 138,300 total→ Common Stock (138,300 underlying)
Footnotes (5)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan, adopted December 9, 2025.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.50 to $5.51, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.50 to $5.54, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- [F5]The initial number of restricted stock units granted shall vest in 12 equal quarterly installments starting on June 8, 2026, provided the Reporting Person continues to have a service relationship with the Issuer at such time. The restricted stock units have no expiration date.
Signature
/s/ Melanie Goins|2026-03-17